Show simple item record

dc.contributor.author Nasser, Rabea
dc.date.accessioned 2023-10-28T12:50:28Z
dc.date.accessioned 2023-11-01T04:47:40Z
dc.date.available 2023-10-28T12:50:28Z
dc.date.available 2023-11-01T04:47:40Z
dc.date.issued 2023
dc.identifier.citation NASSER, Rabea. Renal involvement in Sjogren’s syndrome. In: Revista de Ştiinţe ale Sănătăţii din Moldova = Moldovan Journal of Health Sciences. 2023, vol. 10(3), anexa 1, p. 220. ISSN 2345-1467. en_US
dc.identifier.issn 2345-1467
dc.identifier.uri https://conferinta.usmf.md/wp-content/uploads/Culegerea-Rezumate-MJHS_10_3_2023_anexa1.pdf
dc.identifier.uri http://repository.usmf.md/handle/20.500.12710/25693
dc.description Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, Chişinău, Republica Moldova en_US
dc.description.abstract Introduction. Sjögren’s syndrome (SS) is a chronic autoimmune disorder with lymphocyte infiltration of the exocrine glands, mainly salivary and lacrimal glands, leading to sicca symptoms. Patients develop extraglandular disease of multiple organs; including 5% of patients can have renal involvement. Aim. To describe the evolution of SS and probable renal involvement. Materials and methods. A case a patient with SS. Results. A 43 year old female patient presented with Raynaud’s syndrome, moderate arthralgia in the small joints of the hands, sensation of heat in the hands, xerostomia, xerophthalmia, headache, moderate gastralgia, asthenia, and photosensitivity. The patient has been considered ill since 2014 when inflammation occurred in the salivary glands. The patient went to the emergency hospital where an ultrasound of the salivary glands was performed, and the presumed diagnosis was SS. The patient underwent a salivary gland biopsy which was confirmed the diagnosis. The patient was on GCS exclusively. For the past 2 months, arthralgia has worsened, mainly in the small joints of the hands, and a rash appeared on the left palm. Methylprednisolone was increased to 12 mg and Plaquenil 400 mg tablets was initiated. The patient displayed no symptom of renal disease. However, the work-up depicted proteinuria of 0.5g/24h. Additionally the high disease activity was shown by elevated CICs-130UDO; ANA-6.7>1.2 ·S/CO; FR-51UI/ml; and the diagnosis was serologically confirmed by Anti-Ro ˃240u/ml, Anti-La ˃320u/ml. Conclusion. Renal involvement in SS may have various presentations, tubulointerstitial nephritis and glomerulonephritis being the two most frequent. The presented case is suggestive of glomerular involvement, however biopsy is required to make a final decision. Treatment depends on kidney disease, with electrolyte anomaly correction, corticosteroids and immunosuppressive agents, including B-cell depleting therapy. en_US
dc.publisher Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova en_US
dc.relation.ispartof Revista de Științe ale Sănătății din Moldova: Moldovan Journal of Health Sciences: Conferinţa ştiinţifică anuală "Cercetarea în biomedicină și sănătate: calitate, excelență și performanță", 18-20 octombrie 2023, Chișinău, Republica Moldova en_US
dc.subject Sjögren’s syndrome en_US
dc.subject renal disease en_US
dc.subject treatment en_US
dc.title Renal involvement in Sjogren’s syndrome en_US
dc.type Other en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics